- Home
- IMMP vs STIM Comparison
IMMP vs STIM Comparison
Compare IMMP & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- STIM
- Stock Information
- Founded
- IMMP 1987
- STIM 2003
- Country
- IMMP Australia
- STIM United States
- Employees
- IMMP N/A
- STIM N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- STIM Medical/Dental Instruments
- Sector
- IMMP Health Care
- STIM Health Care
- Exchange
- IMMP Nasdaq
- STIM Nasdaq
- Market Cap
- IMMP 244.5M
- STIM 221.8M
- IPO Year
- IMMP N/A
- STIM 2018
- Fundamental
- Price
- IMMP $1.80
- STIM $4.60
- Analyst Decision
- IMMP Buy
- STIM Buy
- Analyst Count
- IMMP 1
- STIM 4
- Target Price
- IMMP $7.00
- STIM $6.00
- AVG Volume (30 Days)
- IMMP 69.1K
- STIM 865.7K
- Earning Date
- IMMP 02-27-2025
- STIM 08-05-2025
- Dividend Yield
- IMMP N/A
- STIM N/A
- EPS Growth
- IMMP N/A
- STIM N/A
- EPS
- IMMP N/A
- STIM N/A
- Revenue
- IMMP $3,019,249.00
- STIM $89,448,000.00
- Revenue This Year
- IMMP $50.37
- STIM $105.22
- Revenue Next Year
- IMMP N/A
- STIM $11.89
- P/E Ratio
- IMMP N/A
- STIM N/A
- Revenue Growth
- IMMP 24.11
- STIM 22.16
- 52 Week Low
- IMMP $1.32
- STIM $0.52
- 52 Week High
- IMMP $2.72
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- IMMP 59.33
- STIM 71.00
- Support Level
- IMMP $1.60
- STIM $3.62
- Resistance Level
- IMMP $1.83
- STIM $4.82
- Average True Range (ATR)
- IMMP 0.05
- STIM 0.29
- MACD
- IMMP 0.02
- STIM 0.08
- Stochastic Oscillator
- IMMP 84.78
- STIM 83.01
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.